<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
  <head>
    <meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
    		<meta name="keywords" content="Biodefense and Pandemic Vaccine and Drug Development Act of 2005,2002,Approved drug,Associated Press,Autism epidemic,Avian flu,Bill Frist,Biological weapons,Bioterrorism,Center for Responsive Politics,Centers for Disease Control" />
		<link rel="shortcut icon" href="/favicon.ico" />
		<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (English)" />
		<link rel="copyright" href="../../../COPYING.html" />
    <title>Biodefense and Pandemic Vaccine and Drug Development Act of 2005 - Wikipedia, the free encyclopedia</title>
    <style type="text/css">/*<![CDATA[*/ @import "../../../skins/htmldump/main.css"; /*]]>*/</style>
    <link rel="stylesheet" type="text/css" media="print" href="../../../skins/common/commonPrint.css" />
    <!--[if lt IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE50Fixes.css";</style><![endif]-->
    <!--[if IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE55Fixes.css";</style><![endif]-->
    <!--[if IE 6]><style type="text/css">@import "../../../skins/monobook/IE60Fixes.css";</style><![endif]-->
    <!--[if IE]><script type="text/javascript" src="../../../skins/common/IEFixes.js"></script>
    <meta http-equiv="imagetoolbar" content="no" /><![endif]-->
    <script type="text/javascript" src="../../../skins/common/wikibits.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/md5.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/utf8.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/lookup.js"></script>
    <script type="text/javascript" src="../../../raw/gen.js"></script>        <style type="text/css">/*<![CDATA[*/
@import "../../../raw/MediaWiki%7ECommon.css";
@import "../../../raw/MediaWiki%7EMonobook.css";
@import "../../../raw/gen.css";
/*]]>*/</style>          </head>
  <body
    class="ns-0">
    <div id="globalWrapper">
      <div id="column-content">
	<div id="content">
	  <a name="top" id="contentTop"></a>
	        <h1 class="firstHeading">Biodefense and Pandemic Vaccine and Drug Development Act of 2005</h1>
	  <div id="bodyContent">
	    <h3 id="siteSub">From Wikipedia, the free encyclopedia</h3>
	    <div id="contentSub"></div>
	    	    <div class="usermessage">You have <a href="../../../1/2/7/User_talk%7E127.0.0.1.html" title="User talk:127.0.0.1">new messages</a> (<a href="../../../1/2/7/User_talk%7E127.0.0.1.html" title="User talk:127.0.0.1">last change</a>).</div>	    <!-- start content -->
	    <p>The <b>Biodefense and Pandemic Vaccine and Drug Development Act of 2005</b> (S. 1873), nicknamed <b>"Bioshield Two"</b> and sponsored by Senator <a href="../../../r/i/c/Richard_Burr_c3b9.html" title="Richard Burr">Richard Burr</a> (R-<a href="../../../n/o/r/North_Carolina_5c52.html" title="North Carolina">North Carolina</a>), aims to shortcut safety testing for new <a href="../../../v/a/c/Vaccine.html" title="Vaccine">vaccines</a> and <a href="../../../a/p/p/Approved_drug.html" title="Approved drug">drugs</a> in case of a <a href="../../../p/a/n/Pandemic.html" title="Pandemic">pandemic</a>, and to protect vaccine makers and the <a href="../../../p/h/a/Pharmaceutical.html" title="Pharmaceutical">pharmaceutical</a> industry from legal liability for vaccine injuries. The proposed bill would create a new federal agency, the Biomedical Advanced Research and Development Agency (BARDA), that would act "as the single point of authority" to promote advanced research and development of drugs and vaccines in response to <a href="../../../b/i/o/Bioterrorism.html" title="Bioterrorism">bioterrorism</a> and natural <a href="../../../d/i/s/Disease.html" title="Disease">disease</a> outbreaks, while shielding the agency from public <a href="../../../f/r/e/Freedom_of_Information_Act_920f.html" title="Freedom of Information Act">Freedom of Information Act</a> (FOIA) requests. BARDA would be exempt from long-standing open records and meetings laws that apply to most government departments.</p>
<p>The Senate Health, Education, Labor and Pensions Committee approved the bill, co-sponsored by <a href="../../../b/i/l/Bill_Frist_4763.html" title="Bill Frist">Bill Frist</a> (R-<a href="../../../t/e/n/Tennessee.html" title="Tennessee">TN</a>), Mike Enzi (R-<a href="../../../w/y/o/Wyoming.html" title="Wyoming">WY</a>), and Judd Gregg (R-<a href="../../../n/e/w/New_Hampshire_86db.html" title="New Hampshire">NH</a>), by voice vote, despite Democratic objections.</p>
<table id="toc" class="toc" summary="Contents">
<tr>
<td>
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1"><a href="#Key_provisions"><span class="tocnumber">1</span> <span class="toctext">Key provisions</span></a></li>
<li class="toclevel-1"><a href="#Support"><span class="tocnumber">2</span> <span class="toctext">Support</span></a></li>
<li class="toclevel-1"><a href="#Opposition"><span class="tocnumber">3</span> <span class="toctext">Opposition</span></a></li>
<li class="toclevel-1"><a href="#See_also"><span class="tocnumber">4</span> <span class="toctext">See also</span></a></li>
<li class="toclevel-1"><a href="#External_links"><span class="tocnumber">5</span> <span class="toctext">External links</span></a></li>
</ul>
</td>
</tr>
</table>
<p><script type="text/javascript">
//<![CDATA[
 if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } 
//]]>
</script><a name="Key_provisions" id="Key_provisions"></a></p>
<h2><span class="editsection">[<a href="../../../b/i/o/Biodefense_and_Pandemic_Vaccine_and_Drug_Development_Act_of_2005_583f.html" title="Edit section: Key provisions">edit</a>]</span> <span class="mw-headline">Key provisions</span></h2>
<p>The Bioshield Two bill would shift the main responsibility for developing bioterrorism countermeasures out of the <a href="../../../d/e/p/Department_of_Homeland_Security_2981.html" title="Department of Homeland Security">Department of Homeland Security</a> and into the new BARDA agency within the <a href="../../../d/e/p/Department_of_Health_and_Human_Services_b2d7.html" title="Department of Health and Human Services">Department of Health and Human Services</a>. The proposed new agency would improve on Project BioShield, a barely two-year-old program also meant to encourage production of vaccines and drugs.</p>
<p>BARDA would receive a first-year budget of $1 billion. Other key aspects of the proposed legislation include:</p>
<ul>
<li>Provision of rebates or grants as incentives for domestic manufacturing of vaccines and medical countermeasures against <a href="../../../b/i/o/Bioterrorism.html" title="Bioterrorism">bioterrorism</a> and natural <a href="../../../d/i/s/Disease.html" title="Disease">disease</a> outbreaks.</li>
<li>Liability protections for drug makers that develop vaccines for <a href="../../../b/i/o/Biological_weapons.html" title="Biological weapons">biological weapons</a>. The measure would make manufacturers, distibutors, health care providers, or administrators of security countermeasures immune from liability caused by a security countermeasure or any pandemic/epidemic product, by means of a limited antitrust exemption.</li>
<li>Establishment of a single agency, the Biomedical Advanced Research and Development Agency, as the lead federal agency for the development of countermeasures against <a href="../../../b/i/o/Bioterrorism.html" title="Bioterrorism">bioterrorism</a>. The new agency would report directly to the <a href="../../../s/e/c/Secretary_of_Health_and_Human_Services_3665.html" title="Secretary of Health and Human Services">Secretary of Health and Human Services</a>, which would have sole authority to decide whether a manufacturer violated laws mandating drug safety. Citizens would be banned from challenging such decisions in the civil court system. The agency would 'partner' with drug makers while placing information about such partnerships outside of public view.</li>
<li>Extension of some prescription drug patents.</li>
<li>Allow the Department of Health and Human Services to sign exclusive sales contracts with particular manufacturers for a particular product.</li>
<li>Forbid government purchases of <a href="../../../g/e/n/Generic.html" title="Generic">generic</a> versions of such new drugs or vaccines as well as public sales of the products for use as countermeasures.</li>
<li>Exempt countermeasures from certain federal cost oversight requirements.</li>
</ul>
<p><a name="Support" id="Support"></a></p>
<h2><span class="editsection">[<a href="../../../b/i/o/Biodefense_and_Pandemic_Vaccine_and_Drug_Development_Act_of_2005_583f.html" title="Edit section: Support">edit</a>]</span> <span class="mw-headline">Support</span></h2>
<p>Much of the support for the bill comes from <a href="../../../p/h/a/Pharmaceutical_Research_and_Manufacturers_of_America_7ac0.html" title="Pharmaceutical Research and Manufacturers of America">Pharmaceutical Research and Manufacturers of America</a> (PhRMA) and its members. In the <a href="../../../2/0/0/2002.html" title="2002">2002</a> election cycle, PhRMA contributed $3,505,052 to politicians, with 95% going to Republicans. The top recipient in the Senate was the bill's sponsor, Senator Richard Burr, who received $288,684, according to the non-partisan <a href="../../../c/e/n/Center_for_Responsive_Politics_ab19.html" title="Center for Responsive Politics">Center for Responsive Politics</a>.</p>
<p>Senator Burr said the legislation "creates a true partnership" between the federal government, the pharmaceutical industry and academia to "walk the drug companies through the Valley of Death" in bringing a new vaccine or drug to market.</p>
<p>Exemptions from open records and meetings laws would streamline the development process, safeguard national security and protect the proprietary interests of drug companies, say Republican backers of the bill.<a href="http://www.lasvegassun.com/sunbin/stories/bw-other/2005/dec/02/120200005.html" class="external autonumber" title="http://www.lasvegassun.com/sunbin/stories/bw-other/2005/dec/02/120200005.html" rel="nofollow">[1]</a></p>
<p><a name="Opposition" id="Opposition"></a></p>
<h2><span class="editsection">[<a href="../../../b/i/o/Biodefense_and_Pandemic_Vaccine_and_Drug_Development_Act_of_2005_583f.html" title="Edit section: Opposition">edit</a>]</span> <span class="mw-headline">Opposition</span></h2>
<p>The bill is opposed by those who believe the act does nothing to address the perceived threat of a deadly <a href="../../../a/v/i/Avian_flu.html" title="Avian flu">avian flu</a> epidemic in the near-term, and that the bill's market exclusivity provisions would unnecessarily drive up prescription drug costs and further erode the already limited range of legal recourse for vaccine injury victims. Company liability protections should only apply when a product is used in an emergency, and not for other situations, according to critics of the bill.</p>
<p>Some scientists have expressed concern the new agency could draw funds away from the federal <a href="../../../c/e/n/Centers_for_Disease_Control_73db.html" title="Centers for Disease Control">Centers for Disease Control</a> (CDC) and the <a href="../../../n/a/t/National_Institutes_of_Health_5b2b.html" title="National Institutes of Health">National Institutes of Health</a> (NIH), and disrupt their work. The <a href="../../../f/e/d/Federation_of_American_Societies_for_Experimental_Biology_faae.html" title="Federation of American Societies for Experimental Biology">Federation of American Societies for Experimental Biology</a> told Burr it was "troubled over the impact this new agency might have on existing programs at the National Institutes of Health and the Centers for Disease Control and Prevention, particularly in an era of limited funding for discretionary spending."</p>
<p>Opponents are also skeptical of the act because of what they see as the dismal history of injury and poor efficacy of vaccines and anti-viral drugs, and because the proposed act specifically exempts BARDA from the Freedom of Information Act.</p>
<p>The <a href="../../../n/a/t/National_Vaccine_Information_Center_5f1b.html" title="National Vaccine Information Center">National Vaccine Information Center</a> (NVIC) denounced the bill as "a drug company stockholder's dream and a consumer's worst nightmare." According to NVIC, there are currently at least ten different bills pending in Congress containing provisions to shield drug companies from lawsuits including S3, S975, S1437, S1828, S1873, S1880, HR650, HR3154, HR3970, and HR4245.</p>
<p>Senator <a href="../../../c/h/r/Chris_Dodd_5f01.html" title="Chris Dodd">Chris Dodd</a> (D-Connecticut]]) said "Their plan will protect companies that make ineffective or harmful medicines, and because it does not include compensation for those injured by a vaccine or drug, it will discourage first responders and patients from taking medicines to counter a biological attack or disease outbreak."</p>
<p>By protecting the profits of drug companies by shielding vaccine makers from lawsuits, opponents, contend, tax payers will be forced to foot the bill for the life-long costs of caring for the millions of vaccine-injured children.</p>
<p>"The damage already done to our society is already in the trillions of dollars," warns noted autism researcher Dr. <a href="../../../m/a/r/Mark_Geier_f2de.html" title="Mark Geier">Mark Geier</a>, who believes that this may be the greatest <a href="../../../i/a/t/Iatrogenic.html" title="Iatrogenic">iatrogenic</a> epidemic in history, adding "The damage of the 9/11 terrorist attacks, and that of the AIDS epidemic pale when compared to the current <a href="../../../a/u/t/Autism_epidemic.html" title="Autism epidemic">epidemic of autism</a>," he told Veritas.</p>
<p><a name="See_also" id="See_also"></a></p>
<h2><span class="editsection">[<a href="../../../b/i/o/Biodefense_and_Pandemic_Vaccine_and_Drug_Development_Act_of_2005_583f.html" title="Edit section: See also">edit</a>]</span> <span class="mw-headline">See also</span></h2>
<ul>
<li><a href="../../../l/i/s/List_of_vaccine_topics.html" title="List of vaccine topics">List of vaccine topics</a></li>
</ul>
<p><a name="External_links" id="External_links"></a></p>
<h2><span class="editsection">[<a href="../../../b/i/o/Biodefense_and_Pandemic_Vaccine_and_Drug_Development_Act_of_2005_583f.html" title="Edit section: External links">edit</a>]</span> <span class="mw-headline">External links</span></h2>
<ul>
<li><a href="http://biohealthinvestor.com/2007/01/project-bioshield-has-given-biotechs.html" class="external text" title="http://biohealthinvestor.com/2007/01/project-bioshield-has-given-biotechs.html" rel="nofollow">Project BioShield Has Given Biotechs Little Motivation to Protect Americans</a> - BioHealth Investor.com (Sunday, January 14, 2007)</li>
<li><a href="http://www.lasvegassun.com/sunbin/stories/bw-other/2005/dec/02/120200005.html" class="external text" title="http://www.lasvegassun.com/sunbin/stories/bw-other/2005/dec/02/120200005.html" rel="nofollow">LasVegasSun.com</a> - 'GOP Wants to Create Secretive Gov't Agency', Andrew Bridges, <a href="../../../a/s/s/Associated_Press_9ff2.html" title="Associated Press">Associated Press</a> (December 2, 2005)</li>
<li><a href="https://www.mmrs.fema.gov/news/legislative/2005/oct/nlegis2005-10-21.aspx" class="external text" title="https://www.mmrs.fema.gov/news/legislative/2005/oct/nlegis2005-10-21.aspx" rel="nofollow">FEMA.gov</a> - 'Senate Committee Approves Legislation to Promote Bio-Defense Projects', David Ruppe, Global Security Newswire (October 19, 2005)</li>
<li><a href="http://www.newmediaexplorer.org/sepp/2005/10/26/s_1873_pandemic_vaccine_bill_to_put_drug_firms_beyond_reach_of_law.htm" class="external text" title="http://www.newmediaexplorer.org/sepp/2005/10/26/s_1873_pandemic_vaccine_bill_to_put_drug_firms_beyond_reach_of_law.htm" rel="nofollow">NewMediaExplorer.org</a> - 'S 1873: Pandemic Vaccine Bill To Put Drug Firms Beyond Reach Of Law', Sepp Hasslberger (October 26, 2005)</li>
<li><a href="http://www.patentbaristas.com/archives/000269.php" class="external text" title="http://www.patentbaristas.com/archives/000269.php" rel="nofollow">PatentBaristas.com</a> - 'Biodefense and Pandemic Vaccine and Drug Development Act Passes Committee' (October 27, 2005)</li>
<li><a href="http://usa.mediamonitors.net/content/view/full/23115" class="external text" title="http://usa.mediamonitors.net/content/view/full/23115" rel="nofollow">MediaMonitors.net</a> - 'Pharma To Republicans - Time To Pay Up Again', Evelyn Pringle (November 24, 2005)</li>
</ul>

<div class="printfooter">
Retrieved from "<a href="http://en.wikipedia.org../../../b/i/o/Biodefense_and_Pandemic_Vaccine_and_Drug_Development_Act_of_2005_583f.html">http://en.wikipedia.org../../../b/i/o/Biodefense_and_Pandemic_Vaccine_and_Drug_Development_Act_of_2005_583f.html</a>"</div>
	    <div id="catlinks"><p class='catlinks'><a href="../../../c/a/t/Special%7ECategories_101d.html" title="Special:Categories">Categories</a>: <span dir='ltr'><a href="../../../2/0/0/Category%7E2005_in_law.html" title="Category:2005 in law">2005 in law</a></span> | <span dir='ltr'><a href="../../../b/i/o/Category%7EBiotechnology_law_899a.html" title="Category:Biotechnology law">Biotechnology law</a></span></p></div>	    <!-- end content -->
	    <div class="visualClear"></div>
	  </div>
	</div>
      </div>
      <div id="column-one">
	<div id="p-cactions" class="portlet">
	  <h5>Views</h5>
	  <ul>
	    <li id="ca-nstab-main"
	       class="selected"	       ><a href="../../../b/i/o/Biodefense_and_Pandemic_Vaccine_and_Drug_Development_Act_of_2005_583f.html">Article</a></li><li id="ca-talk"
	       class="new"	       ><a href="../../../b/i/o/Talk%7EBiodefense_and_Pandemic_Vaccine_and_Drug_Development_Act_of_2005_e04d.html">Discussion</a></li><li id="ca-current"
	       	       ><a href="http://en.wikipedia.org/wiki/Biodefense_and_Pandemic_Vaccine_and_Drug_Development_Act_of_2005">Current revision</a></li>	  </ul>
	</div>
	<div class="portlet" id="p-logo">
	  <a style="background-image: url(../../../images/wiki-en.png);"
	    href="../../../index.html"
	    title="Main Page"></a>
	</div>
	<script type="text/javascript"> if (window.isMSIE55) fixalpha(); </script>
		<div class='portlet' id='p-navigation'>
	  <h5>Navigation</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-Main-page"><a href="../../../index.html">Main page</a></li>
	     	      <li id="n-Contents"><a href="../../../c/o/n/Wikipedia%7EContents_3181.html">Contents</a></li>
	     	      <li id="n-Featured-content"><a href="../../../f/e/a/Wikipedia%7EFeatured_content_24ba.html">Featured content</a></li>
	     	      <li id="n-currentevents"><a href="../../../c/u/r/Portal%7ECurrent_events_bb60.html">Current events</a></li>
	     	    </ul>
	  </div>
	</div>
		<div class='portlet' id='p-interaction'>
	  <h5>interaction</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-About-Wikipedia"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html">About Wikipedia</a></li>
	     	      <li id="n-portal"><a href="../../../c/o/m/Wikipedia%7ECommunity_Portal_6a3c.html">Community portal</a></li>
	     	      <li id="n-contact"><a href="../../../c/o/n/Wikipedia%7EContact_us_afd6.html">Contact us</a></li>
	     	      <li id="n-sitesupport"><a href="http://wikimediafoundation.org/wiki/Fundraising">Make a donation</a></li>
	     	      <li id="n-help"><a href="../../../c/o/n/Help%7EContents_22de.html">Help</a></li>
	     	    </ul>
	  </div>
	</div>
		<div id="p-search" class="portlet">
	  <h5><label for="searchInput">Search</label></h5>
	  <div id="searchBody" class="pBody">
	    <form action="javascript:goToStatic(3)" id="searchform"><div>
	      <input id="searchInput" name="search" type="text"
	        accesskey="f" value="" />
	      <input type='submit' name="go" class="searchButton" id="searchGoButton"
	        value="Go" />
	    </div></form>
	  </div>
	</div>
	      </div><!-- end of the left (by default at least) column -->
      <div class="visualClear"></div>
      <div id="footer">
    <div id="f-poweredbyico"><a href="http://www.mediawiki.org/"><img src="../../../skins/common/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" /></a></div>	<div id="f-copyrightico"><a href="http://wikimediafoundation.org/"><img src="../../../images/wikimedia-button.png" border="0" alt="Wikimedia Foundation"/></a></div>	<ul id="f-list">
	  	  	  <li id="f-credits">This page was last modified 19:35, 9 March 2007 by Anonymous user(s) of Wikipedia. Based on work by Wikipedia user(s) AAMiller, <a href="../../../o/m/b/User%7EOmbudsman_aae9.html" title="User:Ombudsman">Ombudsman</a>, <a href="../../../k/r/i/User%7EKristenq_db32.html" title="User:Kristenq">Kristenq</a> and <a href="../../../i/n/v/User%7EInvictaHOG_427a.html" title="User:InvictaHOG">InvictaHOG</a>.</li>	  <li id="f-copyright">All text is available under the terms of the <a class='internal' href="../../../t/e/x/Wikipedia%7EText_of_the_GNU_Free_Documentation_License_702a.html" title="Wikipedia:Text of the GNU Free Documentation License">GNU Free Documentation License</a>. (See <b><a class='internal' href="../../../c/o/p/Wikipedia%7ECopyrights_92c4.html" title="Wikipedia:Copyrights">Copyrights</a></b> for details.) <br /> Wikipedia&reg; is a registered trademark of the <a href="http://www.wikimediafoundation.org">Wikimedia Foundation, Inc</a>., a US-registered <a class='internal' href="../../../5/0/1/501%28c%29.html#501.28c.29.283.29" title="501(c)(3)">501(c)(3)</a> <a href="http://wikimediafoundation.org/wiki/Deductibility_of_donations">tax-deductible</a> <a class='internal' href="../../../n/o/n/Non-profit_organization.html" title="Non-profit organization">nonprofit</a> <a href="../../../c/h/a/Charitable_organization.html" title="Charitable organization">charity</a>.<br /></li>	  <li id="f-about"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html" title="Wikipedia:About">About Wikipedia</a></li>	  <li id="f-disclaimer"><a href="../../../g/e/n/Wikipedia%7EGeneral_disclaimer_3e44.html" title="Wikipedia:General disclaimer">Disclaimers</a></li>	  	</ul>
      </div>
    </div>
  </body>
</html>
